Skip to main content

Cohort Analysis, August 6

By August 8, 2021Commentary

The latest cohort analysis, this is the current week version, which just shows that week’s cohort. There is also a cumulative version, which shows the cumulative analysis for each week.  As a reminder, the cohort analysis takes a week’s cases and goes forward during a defined lag period set by research from the CDC and others to identify likely hospitalizations and deaths among that set of cases.  Gives you a sense of whether case rates are changing.  Thanks again to DD.  I am dubious about the rise in hospitalization rates.  Likely reflects reduced testing among the young, reduced detection of infections among the vaccinated, and non CV-19 hospitalizations that are called CV-19 ones.

Join the discussion 3 Comments

  • Jolie says:

    I thought you had stated that Ivermectin(sp) treatment was done in hospital, or at any rate considered a hospital treatment? Could this be part of the hospitalization statistics if more doctors are using it?

    • Kevin Roche says:

      that is remdesivir, which for some bizarre reason the FDA has not approved as an outpatient infusion, so you have to be hospitalized to get it. I don’t think ivermectin requires hospitalization, but I am not 100% on that. Ivermectin is repurposed by physicians, it is not formally approved for use against CV-19 I believe.

  • Jolie says:

    Do some of the hospitalization stats reflect Ivermectin(sp) treatments? BTW if this comment looks redundant it’s because it’s the same person different email. Your blog doesn’t fancy yahoo so I am trying gmail but I’m not a robot I swear.

Leave a comment